Acer Therapeutics Inc (ACER):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Acer Therapeutics Inc (ACER) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7376
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥34,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥68,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥102,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Acer Therapeutics Inc (Acer), formerly Opexa Therapeutics Inc is a pharmaceutical company that offers acquisition, development and commercialization of therapies for patients with serious rare diseases. The company offers treatment of autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. Its late-stage clinical pipeline includes drug candidates for severe genetic disorders such as EDSIVO and celiprolol for vascular Ehlers-Danlos syndrome, and ACER-001, a fully taste-masked, immediate release formulation of sodium phenylbutyrate for urea cycle disorders. It uses T-cell technology platform for the development of patient-specific T-cell therapies. The company operates manufacturing facility, and research and development facilities in the US and Canada. Acer is headquartered in Newton, Massachusetts, the US.

Acer Therapeutics Inc (ACER) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Acer Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Acer Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Acer Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Acer Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Acer Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Acer Therapeutics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Acer Therapeutics Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares for USD12.6 Million 10
Opexa Therapeutics Raises USD13.8 Million in Rights Offering of Units 12
Opexa Therapeutics Completes Public Offering Of Shares For US$8 Million 14
Opexa Therapeutics Completes Underwriters’ Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$19 Million 15
Opexa Therapeutics Completes Private Placement Of Shares For US$0.5 Million 16
Opexa Therapeutics Completes Private Placement Of Units For US$3.2 Million 17
Opexa Therapeutics Private Placement Of Common Stock For US$0.5 Million 19
Opexa Therapeutics Files Prospectus For Public Offering Of Shares 20
Opexa Therapeutics Completes First Tranche Of Private Placement Of Shares For US$0.05 Million 21
Debt Offering 23
Opexa Therapeutics Raises USD4.1 Million in Private Placement of Notes 23
Acer Therapeutics Inc – Key Competitors 24
Acer Therapeutics Inc – Key Employees 25
Acer Therapeutics Inc – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Financial Announcements 27
Aug 13, 2018: Acer Therapeutics reports second quarter 2018 financial results and provides corporate update 27
May 14, 2018: Acer Therapeutics Announces First Quarter 2018 Financial Results 29
Mar 07, 2018: Acer Therapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update 30
Nov 13, 2017: Acer Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update 32
Corporate Communications 33
Feb 05, 2018: Acer Therapeutics Announces Management Team Changes 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Acer Therapeutics Inc, Medical Equipment, Key Facts, 2017 2
Acer Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Acer Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Acer Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Acer Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Acer Therapeutics Inc, Deals By Market, 2012 to YTD 2018 8
Acer Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Acer Therapeutics Completes Underwriters Partial Exercise of Over-Allotment of Public Offering of Shares for USD12.6 Million 10
Opexa Therapeutics Raises USD13.8 Million in Rights Offering of Units 12
Opexa Therapeutics Completes Public Offering Of Shares For US$8 Million 14
Opexa Therapeutics Completes Underwriters' Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$19 Million 15
Opexa Therapeutics Completes Private Placement Of Shares For US$0.5 Million 16
Opexa Therapeutics Completes Private Placement Of Units For US$3.2 Million 17
Opexa Therapeutics Private Placement Of Common Stock For US$0.5 Million 19
Opexa Therapeutics Files Prospectus For Public Offering Of Shares 20
Opexa Therapeutics Completes First Tranche Of Private Placement Of Shares For US$0.05 Million 21
Opexa Therapeutics Raises USD4.1 Million in Private Placement of Notes 23
Acer Therapeutics Inc, Key Competitors 24
Acer Therapeutics Inc, Key Employees 25

List of Figures
Acer Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Acer Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Acer Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Acer Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Acer Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Acer Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Acer Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Acer Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Acer Therapeutics Inc (ACER):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Black Rock Mining Ltd (BKT):企業の財務・戦略的SWOT分析
    Summary Black Rock Mining Ltd (BRML), formerly Green Rock Energy Ltd, is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of graphite properties. It also holds interest in Mahenge Graphite Project which includes high-grade fl …
  • CH2M HILL Companies, Ltd.:企業の戦略・SWOT・財務情報
    CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary CH2M HILL Companies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Cadence Biomedical Inc-医療機器分野:企業M&A・提携分析
    Summary Cadence Biomedical Inc (Cadence), formerly Empowering Engineering Technologies Corp, is a medical device company that provides mobility products. The company offers product such as Kickstart walking system. It provides product to individuals with severe mobility impairments. Cadence’s produc …
  • MGM Resorts International:企業の戦略・SWOT・財務情報
    MGM Resorts International - Strategy, SWOT and Corporate Finance Report Summary MGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Peco Energy Company:電力:M&Aディール及び事業提携情報
    Summary PECO Energy Company (PECO), a subsidiary of Exelon Corporation, is a public utility that purchases and sells electricity and gas, and provides electricity transmission and distribution, and gas distribution services. It supplies electricity and gas to residential, commercial, and industrial …
  • Universal Hospital Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Universal Hospital Services Inc (UHS) is a clinical equipment service company that offers medical equipment management and service solutions. The company offers equipment services and equipment rental services. Its equipment services include clinical engineering, on-site management, surgical …
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • Pudumjee Paper Products Limited:戦略・SWOT・企業財務分析
    Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report Summary Pudumjee Paper Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Unilever N.V.:戦略・SWOT・企業財務分析
    Unilever N.V. - Strategy, SWOT and Corporate Finance Report Summary Unilever N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Adamis Pharmaceuticals Corp (ADMP):企業の財務・戦略的SWOT分析
    Summary Adamis Pharmaceuticals Corp (Adamis) formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company that develops therapies in areas of respiratory disease and allergy. The company offers pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as …
  • Centogene AG-製薬・医療分野:企業M&A・提携分析
    Summary Centogene AG (Centogene) is a provider of genetic testing services. The company offers genetic testing for rare hereditary disorders. It offers whole genome sequencing, whole exome sequencing, biomarker and biochemical testing; prenatal testing, DNA extraction and cell culture services. Cent …
  • Occidental Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Occidental Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Occidental Petroleum Corp (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream a …
  • Swan Life Ltd.:企業の戦略・SWOT・財務情報
    Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report Summary Swan Life Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Msc Industrial Direct Co., Inc.:企業の戦略・SWOT・財務分析
    Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Msc Industrial Direct Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Nordson Corporation:企業の戦略・SWOT・財務情報
    Nordson Corporation - Strategy, SWOT and Corporate Finance Report Summary Nordson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Blueprint Medicines Corp (BPMC):医療機器:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Diamond Offshore Drilling Inc (DO):企業の財務・戦略的SWOT分析
    Diamond Offshore Drilling Inc (DO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Fortis Inc.:企業の戦略・SWOT・財務分析
    Fortis Inc. - Strategy, SWOT and Corporate Finance Report Summary Fortis Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Payton Planar Magnetics Ltd (PAY):企業の財務・戦略的SWOT分析
    Payton Planar Magnetics Ltd (PAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Terumo Corp (4543):企業の財務・戦略的SWOT分析
    Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆